Metastatic Chondroblastoma with Elevated Creatine Kinase and Paraneoplastic Neurologic Autoimmunity

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 11, 2003, Pages 900-904

  Joshi, Divya Devi ^a,b   Anderson, Peter M ^a   Matsumoto, Jane ^a   Moir, Christopher ^a   Shives, Thomas ^a   Unni, Krishnan ^a   Lennon, Vanda A ^a  

^a MAYO CLINIC   (United States)

^b NEMOURS CHILDREN S HOSPITAL   (United States)

Author keywords

Acetylcholine receptor antibody; CRMP 5; Pediatric; Pulmonary metastases; Tumor immunity

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR ANTIBODY; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; CREATINE KINASE; IMMUNOGLOBULIN G; PURKINJE CELL CYTOPLASMIC ANTIBODY 2; UNCLASSIFIED DRUG;

ARTICLE; ASEPTIC MENINGITIS; AUTOIMMUNE DISEASE; CANCER SURGERY; CASE REPORT; CHILD; CHONDROBLASTOMA; CREATINE KINASE BLOOD LEVEL; FEMALE; HUMAN; LUNG CARCINOMA; LUNG METASTASIS; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; THYMOMA; TUMOR IMMUNITY;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; CHONDROBLASTOMA; CREATINE KINASE; FEMALE; HUMANS; LUNG NEOPLASMS; MENINGITIS; NERVE TISSUE PROTEINS; PARANEOPLASTIC SYNDROMES; PURKINJE CELLS; RECEPTORS, CHOLINERGIC;

EID: 0242524449     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200311000-00015     Document Type: Article

References (15)

1. Schuppers HA, van der Eijken JW. Chondroblastoma during the growing age. J Pediatr Orthop. 1998;7:293-297.
2. Jambhekar NA, Desai PB, Chitale DA, et al. Benign metastasizing chondroblastoma. Cancer. 1998;15:675-678.
3. Scarborough MT, Moreau G. Benign cartilage tumors. Orthop Clin North Am. 1996;27:583-589.
4. Swarts SJ, Neff JR, Johansson SL, et al. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop. 1998;349:189-193.
5. Posl M, Werner M, Amling M, et al. Malignant transformation of chondroblastoma. Histopathology. 1996;29:477-480.
6. Kyriakos M, Land VJ, Penning HL, et al. Metastatic chondroblastoma. Report of a fatal case with a review of the literature on atypical, aggressive, and malignant chondroblastoma. Cancer. 1985;55:1770-1789.
7. Seline PC, Jaskierny DJ. Cutaneous metastases from a chondroblastoma initially presenting as unilateral palmar hyperhidrosis. J Am Acad Dermatol. 1999;40:325-327.
8. Khalili K, White LM, Kandel RA, et al. Chondroblastoma with multiple distant soft tissue metastases. Skeletal Radiol. 1997;26:493-496.
9. Rodgers WB, Mankin HJ. Metastatic malignant chondroblastoma. Am J Orthop. 1996;25:846-849.
10. Yu Z, Kryzer TJ, Griesmann GE, et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol. 2001;49:146-154.
11. Vemino S, Lennon VA. New Purkinje cell antibody (PCA-2): Marker of lung cancer-related neurological autoimmunity. Ann Neurol. 2000;47:297-305.
12. Lennon VA. Calcium channel and related paraneoplastic disease autoantibodies. In: Peter JB, Schoenfeld Y, eds. Textbook of autoantibodies. The Netherlands: Elsevier Science Publishers, B.V., 1996:139-147.
13. Lennon VA. Serological diagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome. In: Lisak R, ed. Handbook of myasthenia gravis. New York: Marcel Dekker; 1994:149-164.
14. Povysil C, Tomanova R, Matejovsky Z. Muscle-specific actin expression in chondroblastomas. Hum Pathol. 1997;28:316-320.
15. Schubert D, Lacorbiere M. Phenotypic transformation of clonal myogenic cells to cells resembling chondrocytes. Proc Natl Acad Sci USA. 1976;73:1989-1993.